The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Regenxbio Inc shares valued at $101,052 were sold by KARABELAS ARGERIS N on Oct 01 ’24. At $10.11 per share, KARABELAS ARGERIS N sold 10,000 shares. The insider’s holdings dropped to 11,286 shares worth approximately $96946.74 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, KARABELAS ARGERIS N sold 10,000 shares, netting a total of over 115,588 in proceeds. Following the sale of shares at $11.56 each, the insider now holds 11,286 shares.
Before that, KARABELAS ARGERIS N had sold 10,100 shares from its account. In a trade valued at $136,454, the Director traded Regenxbio Inc shares for $13.51 each. Upon closing the transaction, the insider’s holdings decreased to 10,100 shares, worth approximately $96946.74.
Analysts at Goldman started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of March 11, 2024, H.C. Wainwright has initiated its “Buy” rating for RGNX. Earlier on March 08, 2024, RBC Capital Mkts upgraded its rating. Their new recommendation was “an Outperform” for RGNX stock which previously was a “a Sector perform”.
Analyzing RGNX Stock Performance
During the last five days, there has been a drop of approximately -10.33%. Over the course of the year, Regenxbio Inc shares have dropped approximately -52.14%. Shares of the company reached a 52-week high of $28.80 on 03/05/24 and a 52-week low of $8.56 on 10/31/24. A 50-day SMA is recorded $10.84, while a 200-day SMA reached $14.49. Nevertheless, trading volume fell to 0.5 million shares from 0.4 million shares the previous day.
Support And Resistance Levels for Regenxbio Inc (RGNX)
According to the 24-hour chart, there is a support level at 8.44, which, if violated, would cause prices to drop to 8.29. In the upper region, resistance lies at 8.86. The next price resistance is at 9.13. RSI (Relative Strength Index) is 31.95 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.99, which suggests the price will decrease in the coming days. Percent R is at 99.06%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
